Purchases and Sales Made in Q2 2022 in Hcw Biologics Inc. (HCWB)
This table provides information about the institutional ownership of Hcw Biologics Inc. (HCWB) during Q2 2022. The information is specifically focused on institutions that hold shares of HCW Biologics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2022
Q2 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
16K+ 28.27% |
$31.4K - $50.7K
|
72.6K
$26.9K
|
|
|
Aug 10, 2022
Q2 2022
|
High Tower Advisors, LLC
Chicago, IL |
BUY
|
- |
10K+ 4.64% |
$19.6K - $31.7K
|
226K
$83.5K
|
|
|
Aug 12, 2022
Q2 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
4.38K+ 5.3% |
$8.58K - $13.9K
|
86.9K
$32.2K
|
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
3.3K+ 8.33% |
$6.46K - $10.5K
|
42.9K
$15.9K
|
|
|
Aug 15, 2022
Q2 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.07K+ 493.26% |
$6.02K - $9.74K
|
3.7K
$1.37K
|
|
|
Aug 12, 2022
Q2 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
2.26K+ 4.24% |
$4.42K - $7.15K
|
55.4K
$20.5K
|
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
900+ 4.38% |
$1.76K - $2.85K
|
21.4K
$7.94K
|
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
BUY
|
- |
351+ 20.59% |
$688 - $1.11K
|
2.06K
$761
|
|
|
Aug 12, 2022
Q2 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 9.09% |
$7.84 - $12.7
|
48
$17.8
|
|
|
Aug 09, 2022
Q2 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-11.5K- 22.46% |
$22.5K - $36.5K
|
39.7K
$14.7K
|